A multiscale agent-based in silico model of liver fibrosis progression

Frontiers in Bioengineering and Biotechnology

Volumn 2, Issue MAY, 2014, Pages

  Dutta Moscato, Joyeeta ^a,b,c   Solovyev, Alexey ^c   Mi, Qi ^c   Nishikawa, Taichiro ^c,d   Soto Gutierrez, Alejandro ^a,b,c   Fox, Ira J ^b,c,d   Vodovotz, Yoram ^b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Cirrhosis; Computer simulation; Elastography; Hepatocyte; Inflammation

Indexed keywords

AUTONOMOUS AGENTS; CARBON; CELL CULTURE; COMPUTATIONAL METHODS; COMPUTER SIMULATION; MACROPHAGES; MEDICAL IMAGING; PATHOLOGY; RATS; TENSILE TESTING; TISSUE;

CIRRHOSIS; ELASTOGRAPHY; HEPATIC STELLATE CELLS; HEPATOCYTES; INFLAMMATION; MACROSCOPIC PROPERTIES; THRESHOLD CONCENTRATIONS; TUMOR NECROSIS FACTOR ALPHA;

LIVER;

EID: 85014006395     PISSN: None     EISSN: 22964185     Source Type: Journal    
DOI: 10.3389/fbioe.2014.00018     Document Type: Article

References (51)

1. An, G. (2004). In silico experiments of existing and hypothetical cytokine-directed clinical trials using agent-based modeling. Crit. Care Med. 32, 2050-2060. doi: 10.1097/01.CCM.0000139707.13729.7D
2. An, G., Mi, Q., Dutta-Moscato, J., and Vodovotz, Y. (2009). Agent-based models in translational systems biology. Wiley Interdiscip. Rev. Syst. Biol. Med. 1, 159-171. doi:10.1002/wsbm.45
3. Bahcecioglu, I. H., Koca, S. S., Poyrazoglu, O. K., Yalniz, M., Ozercan, I. H., Ustundag, B., et al. (2008). Hepatoprotective effect of infliximab, an anti-TNF-alpha agent, on carbon tetrachloride-induced hepatic fibrosis. Inflammation 31, 215-221. doi:10.1007/s10753-008-9067-1
4. Bataller, R., and Brenner, D. A. (2005). Liver fibrosis. J. Clin. Invest. 115, 209-218. doi:10.1172/JCI200524282
5. Bell, C. W., Jiang, W., Reich, C. F. III, and Pisetsky, D. S. (2006). The extracellular release of HMGB1 during apoptotic cell death. Am. J. Physiol. Cell Physiol. 291, C1318-C1325. doi:10.1152/ajpcell.00616.2005
6. Bhattacharya, S., Shoda, L. K., Zhang, Q., Woods, C. G., Howell, B. A., Siler, S. Q., et al. (2012). Modeling drug-and chemical-induced hepatotoxicity with systems biology approaches. Front. Physiol. 3:462. doi:10.3389/fphys.2012.00462
7. Bhattacharya-Ghosh, B., Schievano, S., and Diaz-Zuccarini, V. (2012). A multi-physics and multi-scale lumped parameter model of cardiac contraction of the left ventricle: a conceptual model from the protein to the organ scale. Comput. Biol. Med. 42, 982-992. doi:10.1016/j.compbiomed.2012.07.010
8. Brown, B. N., Price, I. M., Toapanta, F. R., DeAlmeida, D. R., Wiley, C. A., Ross, T. M., et al. (2011). An agent-based model of inflammation and fibrosis following particulate exposure in the lung. Math. Biosci. 231, 186-196. doi:10.1016/j.mbs.2011.03.005
9. Castera, L., Vergniol, J., Foucher, J., Le Bail, B., Chanteloup, E., Haaser, M., et al. (2005). Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128, 343-350. doi:10.1053/j.gastro.2004.11.018
10. Constandinou, C., Henderson, N., and Iredale, J. P. (2005). Modeling liver fibrosis in rodents. Methods Mol. Med. 117, 237-250. doi:10.1385/1-59259-940-0:237
11. Edwards, M. J., Keller, B. J., Kauffman, F. C., and Thurman, R. G. (1993). The involvement of Kupffer cells in carbon tetrachloride toxicity. Toxicol. Appl. Pharmacol. 119, 275-279. doi:10.1006/taap.1993.1069
12. Friedman, S. L. (2000). Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275, 2247-2250. doi:10.1074/jbc.275.4.2247
13. Friedman, S. L. (2008). Mechanisms of hepatic fibrogenesis. Gastroenterology 134, 1655-1669. doi:10.1053/j.gastro.2008.03.003
14. Georges, P. C., Hui, J. J., Gombos, Z., McCormick, M. E., Wang, A. Y., Uemura, M., et al. (2007). Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G1147-G1154. doi:10.1152/ajpgi.00032.2007
15. Grimm, V., Revilla, E., Berger, U., Jeltsch, F., Mooij, W. M., Railsback, S. F., et al. (2005). Pattern-oriented modeling of agent-based complex systems: lessons from ecology. Science 310, 987-991. doi:10.1126/science.1116681
16. Hoehme, S., Brulport, M., Bauer, A., Bedawy, E., Schormann, W., Hermes, M., et al. (2010). Prediction and validation of cell alignment along microvessels as order principle to restore tissue architecture in liver regeneration. Proc. Natl. Acad. Sci. U.S.A. 107, 10371-10376. doi:10.1073/pnas.0909374107
17. Huwart, L., Peeters, F., Sinkus, R., Annet, L., Salameh, N., ter Beek, L. C., et al. (2006). Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed. 19, 173-179. doi:10.1002/nbm.1030
18. Iredale, J. P. (2007). Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J. Clin. Invest. 117, 539-548. doi:10.1172/JCI30542
19. Kao, Y. H., Jawan, B., Goto, S., Hung, C. T., Lin, Y. C., Nakano, T., et al. (2008). High-mobility group box 1 protein activates hepatic stellate cells in vitro. Transplant. Proc. 40, 2704-2705. doi:10.1016/j.transproceed.2008.07.055
20. Knittel, T., Muller, L., Saile, B., and Ramadori, G. (1997). Effect of tumour necrosis factor-alpha on proliferation, activation and protein synthesis of rat hepatic stellate cells. J. Hepatol. 27, 1067-1080. doi:10.1016/S0168-8278(97)80151-1
21. Kobayashi, N., Ito, M., Nakamura, J., Cai, J., Gao, C., Hammel, J. M., et al. (2000). Hepatocyte transplantation in rats with decompensated cirrhosis. Hepatology 31, 851-857. doi:10.1053/he.2000.5636
22. Li, N. Y., Verdolini, K., Clermont, G., Mi, Q., Rubinstein, E. N., Hebda, P. A., et al. (2008). A patient-specific in silico model of inflammation and healing tested in acute vocal fold injury. PLoS ONE 3:e2789. doi:10.1371/journal.pone.0002789
23. Liu, L., Yannam, G. R., Nishikawa, T., Yamamoto, T., Basma, H., Ito, R., et al. (2012). The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis. Hepatology 55, 1529-1539. doi:10.1002/hep.24815
24. 2-associated alternative Kupffer cell activation promotes liver fibrosis without inducing local inflammation. Int. J. Biol. Sci. 7, 1273-1286. doi:10.7150/ijbs.7.1273
25. Maher, J. J., and McGuire, R. F. (1990). Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J. Clin. Invest. 86, 1641-1648. doi:10.1172/JCI114886
26. Malarkey, D. E., Johnson, K., Ryan, L., Boorman, G., and Maronpot, R. R. (2005). New insights into functional aspects of liver morphology. Toxicol. Pathol. 33, 27-34. doi:10.1080/01926230590881826
27. Martinez, F. O., Sica, A., Mantovani, A., and Locati, M. (2008). Macrophage activation and polarization. Front. Biosci. 13:453-461. doi:10.2741/2692
28. Meier-Schellersheim, M., Fraser, I. D., and Klauschen, F. (2009). Multiscale modeling for biologists. Wiley Interdiscip. Rev. Syst. Biol. Med. 1, 4-14. doi:10.1002/wsbm.33
29. Mi, Q., Riviere, B., Clermont, G., Steed, D. L., and Vodovotz, Y. (2007). Agent-based model of inflammation and wound healing: insights into diabetic foot ulcer pathology and the role of transforming growth factor-beta1. Wound Repair Regen. 15, 671-682. doi:10.1111/j.1524-475X.2007.00271.x
30. Onori, P., Morini, S., Franchitto, A., Sferra, R., Alvaro, D., and Gaudio, E. (2000). Hepatic microvascular features in experimental cirrhosis: a structural and morphometrical study in CCl4-treated rats. J. Hepatol. 33, 555-563. doi:10.1034/j.1600-0641.2000.033004555.x
31. Park, S., Ropella, G. E., Kim, S. H., Roberts, M. S., and Hunt, C. A. (2009). Computational strategies unravel and trace how liver disease changes hepatic drug disposition. J. Pharmacol. Exp. Ther. 328, 294-305. doi:10.1124/jpet.108.142497
32. Perez Tamayo, R. (1983). Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis? Hepatology 3, 112-120. doi:10.1002/hep.1840030118
33. Popov, Y., and Schuppan, D. (2009). Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 50, 1294-1306. doi:10.1002/hep.23123
34. Rockey, D. C. (2008). Current and future anti-fibrotic therapies for chronic liver disease. Clin. Liver Dis. 12, 939-962, xi. doi:10.1016/j.cld.2008.07.011
35. Roskams, T. (2008). Relationships among stellate cell activation, progenitor cells, and hepatic regeneration. Clin. Liver Dis. 12, 853-860, ix. doi:10.1016/j.cld.2008.07.014
36. Scaffidi, P., Misteli, T., and Bianchi, M. E. (2002). Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191-195. doi:10.1038/nature00858
37. Schuppan, D., and Afdhal, N. H. (2008). Liver cirrhosis. Lancet 371, 838-851. doi:10.1016/S0140-6736(08)60383-9
38. Schuppan, D., Ruehl, M., Somasundaram, R., and Hahn, E. G. (2001). Matrix as a modulator of hepatic fibrogenesis. Semin. Liver Dis. 21, 351-372. doi:10.1055/s-2001-17556
39. Segovia-Juarez, J. L., Ganguli, S., and Kirschner, D. (2004). Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model. J. Theor. Biol. 231, 357-376. doi:10.1016/j.jtbi.2004.06.031
40. Solovyev, A., Mikheev, M., Zhou, L., Dutta-Moscato, J., Ziraldo, C., An, G., et al. (2010). SPARK: a framework for multi-scale agent-based biomedical modeling. Int. J. Agent Technol. Syst. 2, 18-30. doi:10.4018/jats.2010070102
41. Sorensen, T. I., Orholm, M., Bentsen, K. D., Hoybye, G., Eghoje, K., and Christoffersen, P. (1984). Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 2, 241-244. doi:10.1016/S0140-6736(84)90295-2
42. Stachura, J., Tarnawski, A., Ivey, K. J., Mach, T., Bogdal, J., Szczudrawa, J., et al. (1981). Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in the rat. Gastroenterology 81, 211-217.
43. Takeda, T., Yasuda, T., Nakayama, Y., Nakaya, M., Kimura, M., Yamashita, M., et al. (2006). Usefulness of non-invasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C. World J. Gastroenterol. 12, 7768-7773. doi:10.3748/wjg.v12.i48.7768
44. Thannickal, V. J., Lee, D. Y., White, E. S., Cui, Z., Larios, J. M., Chacon, R., et al. (2003). Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J. Biol. Chem. 278, 12384-12389. doi:10.1074/jbc.M208544200
45. Tsukamoto, H., Matsuoka, M., and French, S. W. (1990). Experimental models of hepatic fibrosis: a review. Semin. Liver Dis. 10, 56-65. doi:10.1055/s-2008-1040457
46. Vodovotz, Y., Csete, M., Bartels, J., Chang, S., and An, G. (2008). Translational systems biology of inflammation. PLoS Comput. Biol. 4:e1000014. doi:10.1371/journal.pcbi.1000014
47. Wambaugh, J., and Shah, I. (2010). Simulating microdosimetry in a virtual hepatic lobule. PLoS Comput. Biol. 6:e1000756. doi:10.1371/journal.pcbi.1000756
48. Wang, M. H., Palmeri, M. L., Guy, C. D., Yang, L., Hedlund, L. W., Diehl, A. M., et al. (2009). In vivo quantification of liver stiffness in a rat model of hepatic fibrosis with acoustic radiation force. Ultrasound Med. Biol. 35, 1709-1721. doi:10.1016/j.ultrasmedbio.2009.04.019
49. Wells, R. G. (2008). The role of matrix stiffness in regulating cell behavior. Hepatology 47, 1394-1400. doi:10.1002/hep.22193
50. Wu, J., and Norton, P. A. (1996). Animal models of liver fibrosis. Scand. J. Gastroenterol. 31, 1137-1143. doi:10.3109/00365529609036901
51. Yin, M., Talwalkar, J. A., Glaser, K. J., Manduca, A., Grimm, R. C., Rossman, P. J., et al. (2007). Assessment of hepatic fibrosis with magnetic resonance elastography. Clin. Gastroenterol. Hepatol. 5, e1202. doi:10.1016/j.cgh.2007.06.012